Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development
  2. Li, H. J.; Ji, M.; Klarmann, K. D.; Keller, J. R.
  3. Blood. 2010, Aug 19; 116(7): 1060-1069.
  1. 2.   Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
  2. Stuelten, C. H.; Mertins, S. D.; Busch, J. I.; Gowens, M.; Scudiero, D. A.; Burkett, M. W.; Hite, K. M.; Alley, M.; Hollingshead, M.; Shoemaker, R. H.; Niederhuber, J. E.
  3. Stem Cells. 2010, Apr; 28(4): 649-660.
  1. 3.   The role of p202 in regulating hematopoietic cell proliferation and differentiation
  2. Ludlow, L. E.; Purton, L. E.; Klarmann, K.; Gough, D. J.; Hii, L. L.; Trapani, J. A.; Keller, J. R.; Clarke, C.; Johnstone, R. W.
  3. Journal of Interferon and Cytokine Research. 2008 28(1): 5-11.
  1. 4.   Interleukin-7 receptor expression: intelligent design
  2. Mazzucchelli, R.; Durum, S. K.
  3. Nature Reviews Immunology. 2007, Feb; 7(2): 144-154.
  1. 5.   IL-3-mediated TNF production is necessary for mast cell development
  2. Wright, H. V.; Bailey, D.; Kashyap, M.; Kepley, C. L.; Drutskaya, M. S.; Nedospasov, S. A.; Ryan, J. J.
  3. Journal of Immunology. 2006, FEB 15; 176(4): 2114-2121.
  1. 6.   Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway
  2. Lee, H. S.; Bong, Y. S.; Moore, K. B.; Soria, K.; Moody, S. A.; Daar, I. O.
  3. Nature Cell Biology. 2006, JAN; 8(1): 55-63.
  1. 7.   Retroviral transduction of IL-7R alpha into IL-7R alpha(-/-) bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia
  2. Jiang, Q.; Li, W. Q.; Aiello, F. B.; Klarmann, K.; Keller, J. R.; Durum, S. K.
  3. Gene Therapy. 2005, DEC; 12(24): 1761-1768.
  1. 8.   Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice
  2. Drutskaya, M. S.; Ortiz, M.; Liepinsh, D. J.; Kuprash, D. V.; Nedospasov, S. A.; Keller, J. R.
  3. Experimental Hematology. 2005, NOV; 33(11): 1348-1356.
  1. 9.   Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development
  2. Perantoni, A. O.; Timofeeva, O.; Naillat, F.; Richman, C.; Pajni-Underwood, S.; Wilson, C.; Vainio, S.; Dove, L. F.; Lewandoski, M.
  3. Development. 2005, SEP; 132(17): 3859-3871.
  1. 10.   IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development
  2. Leeanansaksiri, W.; Wang, H.; Gooya, J. M.; Renn, K.; Abshari, M.; Tsai, S.; Keller, J. R.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 7014-7021.
  1. 11.   Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials
  2. Yang, Q. E.; Fong, S. E.; Li, K. G.; Gonda, M. A.; Tobin, G. J.
  3. Medical Science Monitor. 2005, JUN; 11(6): BR154-BR161.
  1. 12.   CCAAT enhancer binding protein-alpha (C/EBP alpha) determines myeloid versus erythroid cell fate in multipotential progenitors
  2. Suh, H. C.; Gooya, J.; Renn, K.; Friedman, A.; Johnson, P.; Keller, J.
  3. Blood. 2004, NOV 16; 104(11, Part 1): 446A, Abstract 1603-446A, Abstract 1603.
  1. 13.   Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit
  2. Lennartsson, J.; Shivakrupa, R.; Linnekin, D.
  3. Journal of Biological Chemistry. 2004, OCT 22; 279(43): 44544-44553.
  1. 14.   C/EBP alpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo
  2. Heath, V.; Suh, H. C.; Holman, M.; Renn, K.; Gooya, J. M.; Parkin, S.; Klarmann, K. D.; Ortiz, M.; Johnson, P.; Keller, J.
  3. Blood. 2004, SEP 15; 104(6): 1639-1647.
  1. 15.   JAK2 contributes to the intrinsic capacity of primary hematopoietic cells to respond to stem cell factor
  2. Radosevic, N.; Winterstein, D.; Keller, J. R.; Neubauer, H.; Pfeffer, K.; Linnekin, D.
  3. Experimental Hematology. 2004 32(2): 149-156.
  1. 16.   Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis
  2. Welniak, L. A.; Karas, M.; Yakar, S.; Anver, M. R.; Murphy, W. F.; LeRoith, D.
  3. Biology of Blood and Marrow Transplantation. 2004 10(1): 32-39.
  1. 17.   Chemistry of the diazeniumdiolates. RHN[N(O)NO](-) ions as progenitors of both nitroxyl and nitric oxide
  2. Srinivasan, A.; Citro, M. L.; Davies, K. M.; Espey, M. G.; Keefer, L. K.; Miranda, K. M.; Ridnour, L. A.; Saavedra, J. E.; Thomas, L.; Thomas, D. D.; Waterhouse, D. J.; Wink, D. A.
  3. Chemical Research in Toxicology. 2004 17(12, Abstract 54): 1769-1769.
  1. 18.   Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell- factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation
  2. Akel, S.; Petrow-Sadowski, C.; Laughlin, M. J.; Ruscetti, F. W.
  3. Stem Cells. 2003 21(5): 557-567.
  1. 19.   Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer
  2. Kadereit, S.; Deeds, L. S.; Haynesworth, S. E.; Koc, O. N.; Kozik, M. M.; Szekely, E.; Daum-Woods, K.; Goetchius, G. W.; Fu, P. F.; Welniak, L. A.; Murphy, W. J.; Laughlin, M. J.
  3. Stem Cells. 2002 20(6): 573-582.
  1. 20.   NK inhibitory-receptor blockade for purging of leukemia: Effects on hematopoietic reconstitution
  2. Koh, C. Y.; Raziuddin, A.; Welniak, L. A.; Blazar, B. R.; Bennett, M.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2002 8(1): 17-25.
  1. 21.   Effects of growth hormone and prolactin on hematopoiesis
  2. Welniak, L. A.; Tian, Z. G.; Sun, R.; Keller, J. R.; Richards, S.; Ruscetti, F. W.; Murphy, W. J.
  3. Leukemia & Lymphoma. 2000 38(5-6): 435-445.
  1. 22.   Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region
  2. Hara, T.; Nakano, Y.; Tanaka, M.; Tamura, K.; Sekiguchi, T.; Minehata, K.; Copeland, N. G.; Jenkins, N. A.; Okabe, M.; Kogo, H.; Mukouyama, Y.; Miyajima, A.
  3. Immunity. 1999 11(5): 567-578.
  1. 23.   Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine
  2. Woody, M. A.; Welniak, L. A.; Sun, R.; Tian, Z. G.; Henry, M.; Richards, S.; Raziuddin, A.; Longo, D. L.; Murphy, W. J.
  3. Experimental Hematology. 1999 27(5): 811-816.
  1. 24.   Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation
  2. Nelson, E. L.; Strobl, S.; Subleski, J.; Prieto, D.; Kopp, W. C.; Nelson, P. J.
  3. Faseb Journal. 1999 13(14): 2021-2030.
  1. 25.   Flavopiridol Induces Apoptosis of Normal Lymphoid Cells, Causes Immunosuppression, and Has Potent Antitumor Activity in Vivo Against Human Leukemia and Lymphoma Xenografts
  2. Arguello, F.; Alexander, M.; Sterry, J. A.; Tudor, G.; Smith, E. M.; Kalavar, N. T.; Greene, J. F.; Koss, W.; Morgan, C. D.; Stinson, S. F.; Siford, T. J.; Alvord, W. G.; Klabansky, R. L.; Sausville, E. A.
  3. Blood. 1998 91(7): 2482-2490.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel